Credit Suisse Investment Banking Pitch Book slide image

Credit Suisse Investment Banking Pitch Book

3 Tax benefit analysis - no S382 limitation ($ in millions, except per share amounts) EBIT Tax shielding NOLs used % tax rate Annual savings Limitation on pre-tax income for NOL usage Post-2022 NOL schedule NOL starting balance NOLS generated NOLs expired NOL usage NOL ending balance Sensitivities Discount rate (%) 13.0% 14.5% 16.0% Discount rate (%) 13.0% 14.5% 16.0% 2.0% Source: (1) (2) $91 268.550 $0.34 $82 265.758 $0.31 $73 265.295 $0.28 2.0% $1.43 $0.34 $1.77 $1.05 $0.31 $1.36 2022A $0.76 $0.28 $1.03 $601 Perpetuity growth rate 3.0% $91 269.648 $0.34 $82 266.093 $0.31 $73 265.358 $0.28 Reconciliation to total equity value per share Perpetuity growth rate 3.0% $1.58 $0.34 $1.92 $1.15 $0.31 $1.46 2023E ($119) $0.83 $0.28 $1.11 29% $601 $119 $720 4.0% $91 271.880 $0.33 $82 267.275 $0.31 $73 265.440 $0.28 4.0% 2024E ($104) 29% $720 $104 $824 2025E ($64) 29% $824 $64 $889 Implied net present value Fully diluted shares(1) Implied net present value per share Implied net present value Fully diluted shares(1) Implied net present value per share Implied net present value Fully diluted shares(1) Implied net present value per share 2026E ($13) $1.75 Equity value per share standalone DCF $0.33 Net present value per share - tax benefits $2.09 Implied total equity value per share $1.27 Equity value per share standalone DCF $0.31 Net present value per share - tax benefits $1.58 Implied total equity value per share $0.92 Equity value per share - standalone DCF $0.28 Net present value per share - tax benefits $1.19 Implied total equity value per share 29% $889 $13 $902 2027E $59 47 29% $13 $902 ■ $47 ■ Calendar year ended 2028E $83 ($47) $854 67 29% $19 $67 $854 ($67) Assumptions $788 2029E $110 88 29% $25 $88 $788 ($88) $700 2030E $136 109 29% $31 $109 $700 ($109) $591 2031E $163 130 29% $37 $130 $591 ($130) $461 2032E $188 Company filings, Bravo management, IRS bulletin as of 2/23. Based on fully diluted shares derived from discounted cash flow analysis excluding tax benefits. Per Bravo management, for the purposes of computing the maximum amount of tax savings usable each year beyond 2033, top line assumed to grow at 3.0% in perpetuity with constant EBITDA and D&A margin. 151 29% $43 $151 $461 ($0) ($151) $310 2033E $212 170 29% $48 $170 ■ DCF discounted to 12/31/2022 Mid-year discounting convention Assumes beginning tax asset balance of $600.7m as of 12/31/22 ($589.0m federal and state NOLs and $11.7m R&D tax credits) per Bravo management $310 ($1) ($170) $140 Implied net present value of tax benefits assumes full utilization of NOLs by 2034 per Bravo management (taking into account NOL expiration) (2) Limitation on pre-tax income for NOL usage is equal to 80% of pre-tax income Assumes unlevered free cash flow projections discounted using assumed 13.0%-16.0% WACC Assumes tax rate of 29.0% per Bravo management 10
View entire presentation